TAL6004 regulatory update

FDA's Blood Products Advisory Committee will meet July 20 to discuss clinical and surrogate endpoints for evaluating efficacy of alpha-1 proteinase inhibitors to treat alpha-antitrypsin ( AAT) deficie...